The diarrhea therapeutics market has proven to be effective in tackling diarrhea, which is one of the leading causes of death among children globally. Diarrhea therapeutics help rehydrate the body and restore the lost electrolytes. Mainstay diarrhea therapeutics include over-the-counter oral rehydration solutions and prescription drugs targeting the pathogen or the symptoms.
The Global Diarrhea Therapeutics Market is estimated to be valued at US$ 3.9 Bn in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the diarrhea therapeutics market are Vedanta Biosciences, Inc.,RedHill Biopharma Limited,Hunazine Biotech,Eveliqure Biotechnologies GmbH, and Cosmo Pharmaceuticals. These players are focusing on developing novel microbiome-based therapies.
Growing prevalence of diarrhea especially in developing nations is a key factor driving the demand for anti-diarrheal drugs. As per WHO, diarrhea claims over 525,000 children lives each year globally.
The market is witnessing expansion in regions with high burden of diarrhea such as Asia Pacific and Latin America. Various initiatives by government and non-profit organizations to provide access to diarrhea treatment in these regions are boosting the market growth.
Market key trends
One of the key trends witnessed in the diarrhea therapeutics market is the emergence of microbiome-based therapies. Several players are conducting research around microbiome-targeting approaches such as fecal microbiota transplantation and microbiome modulators like VE202 from Vedanta Biosciences. These therapies aim to restore the balance of beneficial microbes in gut to cure diarrhea. Such innovative approaches are expected to transform the diarrhea treatment landscape in the coming years.
Porter’s Analysis
Threat of new entrants: High capital requirements and strict regulations makes entry difficult.
Bargaining power of buyers: Large customer base with diverse needs increases buyer power.
Bargaining power of suppliers: Dependence on few API makers weakens supplier bargaining power.
Threat of new substitutes: Availability of alternative therapies presents substitutes threat.
Competitive rivalry: Intense competition due to many established companies increases rivalry.
Geographical Regions
North America dominates the market with over 40% share in 2024 due to higher healthcare spending and regulatory approvals for new products.
Asia Pacific region is expected to grow at the fastest CAGR during the forecast period driven by rising incidence of diarrhea associated with changing lifestyles and food habits in emerging countries like India and China.
Geographical Regions
North America dominates the market with over 40% share in 2024 due to higher healthcare spending and regulatory approvals for new products.
Asia Pacific region is expected to grow at the fastest CAGR during the forecast period driven by rising incidence of diarrhea associated with changing lifestyles and food habits in emerging countries like India and China.
What Are The Key Data Covered In This Keyword Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Keyword's growth between 2024 and 2031.
:- Accurate calculation of the size of the Keyword and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Keyword Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Keyword vendors
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
